Adrenaline auto‐injector prescription for patients at risk of anaphylaxis: BSACI guidance for primary care
Clinical & Experimental Allergy · 2023
DOI: 10.1111/cea.14325 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical & Experimental Allergy, 2023. Verfasst von Elizabeth Angier und 6 weiteren Autor:innen. Beteiligte Einrichtung: Primary Care, Population Science and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK. Hauptthemen laut MEDLINE: Epinephrine, Anaphylaxis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Primary Care, Population Science and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
- Portfolio GPwSI Allergy Bedfordshire Luton and Milton Keynes Integrated Care System, Luton, UK.
- Children's Allergy Service, University Hospitals of Leicester, Leicester, UK.
- Anaphylaxis UK, Farnborough, UK.
- Allergy UK, Kent, UK.
- Cambridge University, NHS Foundation Trust, Allergy Clinic, Cambridge, UK.
ORCID-Profile: Elizabeth Angier, David Luyt, Pamela Ewan
Zitieren
APA
Angier, E., Choudhury, D., Luyt, D., Baker, S., Warner, A., Clark, A., & Ewan, P. (2023). Adrenaline auto‐injector prescription for patients at risk of anaphylaxis: BSACI guidance for primary care. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.14325
Vancouver
Angier E, Choudhury D, Luyt D, Baker S, Warner A, Clark A, et al. Adrenaline auto‐injector prescription for patients at risk of anaphylaxis: BSACI guidance for primary care. Clinical & Experimental Allergy. 2023. doi:10.1111/cea.14325
BibTeX
@article{Angier2023,
author = {Angier, Elizabeth and Choudhury, Deepa and Luyt, David and Baker, Sarah and Warner, Amena and Clark, Andrew and Ewan, Pamela},
title = {Adrenaline auto‐injector prescription for patients at risk of anaphylaxis: BSACI guidance for primary care},
journal = {Clinical & Experimental Allergy},
year = {2023},
doi = {10.1111/cea.14325}
}
EUVIMED